Si-bone, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Jeffrey W Dunn, a Director of SI-BONE, Inc., sold 20,000 shares of common stock on August 3, 2026 for $18.46 per share.
NASDAQ
SI-BONE, Inc. executive Michael A. Pisetsky reported the sale of company stock to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
SI-BONE, Inc. Chief Financial Officer Anshul Maheshwari sold shares to cover tax obligations related to restricted stock unit vesting.
NASDAQ
SI-BONE, Inc. reports that Director Jeryl L. Hilleman acquired 10,957 shares through the settlement of restricted stock units.
NASDAQ
Director Jeffrey W. Dunn acquired restricted stock units and executed a mandatory sell-to-cover transaction for tax obligations.
NASDAQ
Director Mika Nishimura was granted 10,957 restricted stock units as part of her ongoing service to SI-BONE, Inc.
NASDAQ
Director Thomas A. West was granted 10,957 restricted stock units as part of his compensation for service to SI-BONE, Inc.
NASDAQ
Director John Freund was granted 10,957 restricted stock units as part of his compensation for service on the SI-BONE board.
NASDAQ
SI-BONE, Inc. director Timothy E. Davis Jr. was granted 10,957 restricted stock units as part of his board compensation.
NASDAQ
Director Timothy E. Davis Jr. exercised stock options and sold shares of SI-BONE, Inc. in late May 2026.
NASDAQ
SI-BONE, Inc. reports that CEO Laura Francis sold shares to cover tax obligations related to restricted stock unit vesting.
NASDAQ
SI-BONE, Inc. Chief Financial Officer Anshul Maheshwari sold 4,666 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Director Jeffrey W. Dunn sold 337 shares of SI-BONE, Inc. to satisfy tax withholding obligations related to restricted stock unit vesting.
NASDAQ
SI-BONE, Inc. reports a Form 4 filing detailing stock transactions by Director Greg K. Hinckley.
NASDAQ
SI-BONE, Inc. Chief Financial Officer Anshul Maheshwari sold company stock to cover tax obligations related to vested restricted stock units.
NASDAQ
Michael A. Pisetsky, SVP of Operations & Administration and Chief Legal Officer at SI-BONE, Inc., reported the sale of company shares to cover tax withholding obligations upon the vesting of restricted stock units.
NASDAQ
SI-BONE, Inc. Director Mika Nishimura reported the sale of 4,100 shares of common stock at a weighted average price of $13.8293 per share, executed under a Rule 10b5-1 plan.
NASDAQ
Anthony J. Recupero, former President of Commercial Operations at SI-BONE, Inc., sold common stock to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Michael A. Pisetsky, SVP, Operations & Administration, and Chief Legal Officer of SI-BONE, Inc., reported the acquisition of restricted stock units and subsequent sales to cover tax withholding obligations.
NASDAQ
SI-BONE CEO Laura Francis reported the grant of 229,481 restricted stock units and the sale of 93,475 shares to cover tax obligations.
NASDAQ
SI-BONE's Chief Financial Officer, Anshul Maheshwari, reported the acquisition of restricted stock units and subsequent non-discretionary sales to cover tax obligations.
NASDAQ
SI-BONE Director Jeffrey W. Dunn reported a non-discretionary sale of 337 common shares to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
SI-BONE, Inc. Director Jeffrey W. Dunn reported the future sale of 20,000 common shares at a weighted-average price of $21.2753, executed under a 10b5-1 trading plan.
NASDAQ
SI-BONE's President of Commercial Operations, Anthony J. Recupero, sold shares to cover tax withholding obligations related to restricted stock unit vesting.
NASDAQ
Michael A. Pisetsky, SI-BONE's SVP, Operations & Administration/Chief Legal Officer, sold common stock to cover tax withholding obligations from restricted stock unit vesting.
NASDAQ
SI-BONE, Inc.'s CFO, Anshul Maheshwari, reported the sale of 5,229 shares of common stock for tax obligations and under a pre-arranged 10b5-1 trading plan.
NASDAQ
SI-BONE's SVP, Operations & Administration/Chief Legal Officer, Michael A. Pisetsky, sold 19,600 shares of common stock for approximately $20.15 per share.
NASDAQ
SI-BONE's Chief Financial Officer, Anshul Maheshwari, sold 18,542 shares of common stock for approximately $20.15 per share under a pre-arranged trading plan.
NASDAQ
SI-BONE Director Jeffrey W. Dunn exercised stock options and subsequently sold a portion of his common stock holdings, including shares held by a trust, under a pre-arranged 10b5-1 plan.
NASDAQ
SI-BONE's SVP, Ops & Adm/Chief Legal Officer, Michael A. Pisetsky, sold 400 shares of common stock for $20 per share on November 24, 2025, as part of a pre-arranged trading plan.